Patents by Inventor Shao-Lee Lin

Shao-Lee Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
    Publication number: 20220340667
    Abstract: The invention provides a method of treating or reducing the severity of thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), or a symptom or aspect thereof, in subjects that have undergone prior treatment for TAO, TED, or GO, and either did not respond to said prior treatment or relapsed after said prior treatment. The invention also provides antibodies, or antigen binding fragments thereof, and pharmaceutical compositions useful in the disclosed methods.
    Type: Application
    Filed: November 19, 2021
    Publication date: October 27, 2022
    Inventors: David MADDEN, Kathleen GABRIEL, Guido MAGNI, Richard WOODWARD, Shao-Lee LIN, Jeffrey W. SHERMAN
  • Methods for the treatment of thyroid eye disease
    Patent number: 11208490
    Abstract: The invention provides a method of treating or reducing the severity of thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), or a symptom or aspect thereof, in subjects that have undergone prior treatment for TAO, TED, or GO, and either did not respond to said prior treatment or relapsed after said prior treatment. The invention also provides antibodies, or antigen binding fragments thereof, and pharmaceutical compositions useful in the disclosed methods.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: December 28, 2021
    Assignee: Horizon Therapeutics Ireland DAC
    Inventors: David Madden, Kathleen Gabriel, Guido Magni, Richard Woodward, Shao-Lee Lin, Jeffrey W. Sherman
  • METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
    Publication number: 20190270820
    Abstract: The invention provides a method of treating or reducing the severity of thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), or a symptom or aspect thereof, in subjects that have undergone prior treatment for TAO, TED, or GO, and either did not respond to said prior treatment or relapsed after said prior treatment. The invention also provides antibodies, or antigen binding fragments thereof, and pharmaceutical compositions useful in the disclosed methods.
    Type: Application
    Filed: March 5, 2019
    Publication date: September 5, 2019
    Inventors: David MADDEN, Kathleen GABRIEL, Guido MAGNI, Richard WOODWARD, Shao-Lee LIN, Jeffrey W. SHERMAN
  • METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS
    Publication number: 20190247503
    Abstract: Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.
    Type: Application
    Filed: September 21, 2018
    Publication date: August 15, 2019
    Inventors: Steven J. Greenberg, Bernhard K. Mueller, Andreas Popp, Matthew R. Rosebraugh, George M. Haig, Shao-Lee Lin
  • METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS
    Publication number: 20170073420
    Abstract: Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.
    Type: Application
    Filed: September 9, 2016
    Publication date: March 16, 2017
    Inventors: Steven J. Greenberg, Bernhard K. Mueller, Andreas Popp, Matthew R. Rosebraugh, George M. Haig, Shao-Lee Lin
  • TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE WITH SYK INHIBITORS
    Publication number: 20160375019
    Abstract: The present disclosure provides methods of utilizing Syk inhibiting compounds in the treatment for graft versus host disease (GVHD) in a human, including acute graft versus host disease (aGVHD) and chronic graft versus host disease (cGVHD), including the use of compounds selected from the group consisting of the formulas below:
    Type: Application
    Filed: April 19, 2016
    Publication date: December 29, 2016
    Inventors: Julie A. Di Paolo, Joseph Haw-Ling Lin, Shao-Lee Lin